(Q32052206)

5 July 2017

title

Stroke and idiopathic Parkinson's disease: does a shortage of dopamine offer protection against stroke? (English)

1 reference

5 July 2017

0 references

0 references

0 references

Korten A

1

1 reference

5 July 2017

Lodder J

2

1 reference

5 July 2017

Vreeling F

3

1 reference

5 July 2017

Boreas A

4

1 reference

5 July 2017

van Raak L

5

1 reference

5 July 2017

Kessels F

6

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

16

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

119-123

1 reference

Parkinson's disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990.

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Cause of death among patients with Parkinson's disease: a rare mortality due to cerebral haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index-stroke subtype, vascular risk factors, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Significant progression of white matter lesions and small deep (lacunar) infarcts in patients with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Epidemiology of stroke in Tilburg, the Netherlands. The population-based stroke incidence register: 2. Incidence, initial clinical picture and medical care, and three-week case fatality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Stroke in a French prospective population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Large striatocapsular infarcts: clinical presentation and pathogenesis in comparison with lacunar and cortical infarcts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Cognitive and Neurologic Findings in Subjects With Diffuse White Matter Lucencies on Computed Tomographic Scan (Leuko-Araiosis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Dopamine and glutamate neurotoxicity in cultured chick telencephali cells: effects of NMDA antagonists, antioxidants and MAO inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Nigral endothelial dysfunction, homocysteine, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Meta-analysis of relation between cigarette smoking and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Prevalence of Parkinson's disease in the elderly: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

[Evaluation of vascular risk factors in patients with Parkinson syndrome]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Stroke and its modification in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Elevated plasma levels of homocysteine in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

Hypotensive effect of long-term levodopa in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C119%3A%3AAID-MDS1024%3E3.0.CO%3B2-W

10.1002/1531-8257(200101)16:1<119::AID-MDS1024>3.0.CO;2-W

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference